Christina Yau, PhD
Developing biomarker-informed patient-centered clinical trial designs to improve outcomes and minimize toxicity
My research focuses on identifying predictive biomarkers of response and refining clinical trial endpoints. The goal is to develop patient-centered, biomarker-informed clinical trial designs to identify novel regimens that improve outcomes while minimizing toxicity for early stage breast cancer patients.